Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
SAVA
$3.42
-4.47%
Analyze
1M
+14.4%
3M
+45.5%
1Y
-87.1%
Market Cap:
$165.21M
Cassava Sciences Inc
Healthcare |
Biotechnology
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
Click "Analyze" to generate stock analysis
SAVA Price Trend and Signals
SAVA Option Volumes & Open Interests (aggregated)
SAVA Put Call Ratios and IV (aggregated)
SAVA Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-22
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-15
Somewhat Bullish
price_signal
Half-yearly high detected.
2025-10-14
Somewhat Bullish
price_signal
Half-yearly high detected.
2025-10-09
Somewhat Bullish
price_signal
Half-yearly high detected.